Evidence against requirement of Ser41 and Ser45 for function of PU.1 - Molecular cloning of rat PU.1

被引:4
作者
Nishiyama, C
Masuoka, N
Nishiyama, M
Ito, T
Yamane, H
Okumura, K
Ogawa, H
机构
[1] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan
[2] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan
来源
FEBS LETTERS | 2004年 / 572卷 / 1-3期
关键词
PU.1; transcription factor; Ser; hematopoiesis;
D O I
10.1016/j.febslet.2004.07.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor PU.1 plays an important role in the development of the myeloid and lymphoid lineages and regulates the transcription of several genes expressed in these cells. Ser41 is conserved in the acidic region (33-47) of PU.1 from a variety of eukaryocytes and has been reported to be one of the two important Ser residues (S41 and S45) for the function of PU.1. In the present study, however, we found that rat PU.1 has Gly at position 41. To elucidate the role of amino acid residues at 41 and 45 in functions of PU.1, we generated mutants of rat PU.1, G41S, G41A, and S45A, and analyzed their transcription-enhancing activities by using two different systems, transient reporter assay system and retroviral transfection system. The amino acid substitution at 41 of PU.1 causes no effect on both transcription-enhancing activity for M-CSF receptor promoter and the cooperative transcription-enhancing activity with GATA-1 for FcepsilonRI alpha-chain promoter. Furthermore, the substitution at 41 also had no effect on the activity to induce monocyte-specific gene expression in the bone marrow-derived hematopoietic cells. From these results, we conclude that Ser41 as well as Ser45 are not essential for the promoter-upregulating function of PU.1. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 35 条
[11]   Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment [J].
Iwama, A ;
Osawa, M ;
Hirasawa, R ;
Uchiyama, N ;
Kaneko, S ;
Onodera, M ;
Shibuya, K ;
Shibuya, A ;
Vinson, C ;
Tenen, DG ;
Nakauchi, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :547-558
[12]   Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1 [J].
Kim, J ;
Feldman, RA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (06) :1903-1918
[13]   THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[14]   The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages [J].
Lloberas, J ;
Soler, C ;
Celada, A .
IMMUNOLOGY TODAY, 1999, 20 (04) :184-189
[15]  
Lodie TA, 1997, J IMMUNOL, V158, P1848
[16]   Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities [J].
McKercher, SR ;
Torbett, BE ;
Anderson, KL ;
Henkel, GW ;
Vestal, DJ ;
Baribault, H ;
Klemsz, M ;
Feeney, AJ ;
Wu, GE ;
Paige, CJ ;
Maki, RA .
EMBO JOURNAL, 1996, 15 (20) :5647-5658
[17]  
MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449
[18]   Plat-E: an efficient and stable system for transient packaging of retroviruses [J].
Morita, S ;
Kojima, T ;
Kitamura, T .
GENE THERAPY, 2000, 7 (12) :1063-1066
[19]  
Nishiyama C, 1999, J IMMUNOL, V163, P623
[20]   Functional analysis of PU.1 domains in monocyte-specific gene regulation [J].
Nishiyama, C ;
Nishiyama, M ;
Ito, T ;
Masaki, S ;
Masuoka, N ;
Yamane, H ;
Kitamura, T ;
Ogawa, H ;
Okumura, K .
FEBS LETTERS, 2004, 561 (1-3) :63-68